1. Home
  2. ROIV vs CSL Comparison

ROIV vs CSL Comparison

Compare ROIV & CSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$21.67

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Logo Carlisle Companies Incorporated

CSL

Carlisle Companies Incorporated

HOLD

Current Price

$330.85

Market Cap

13.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
CSL
Founded
2014
1917
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
13.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ROIV
CSL
Price
$21.67
$330.85
Analyst Decision
Strong Buy
Buy
Analyst Count
8
6
Target Price
$21.94
$386.67
AVG Volume (30 Days)
6.7M
454.8K
Earning Date
11-10-2025
02-03-2026
Dividend Yield
N/A
1.33%
EPS Growth
N/A
N/A
EPS
N/A
17.56
Revenue
$20,329,000.00
$5,015,100,000.00
Revenue This Year
N/A
$1.01
Revenue Next Year
$376.94
$2.69
P/E Ratio
N/A
$18.85
Revenue Growth
N/A
0.14
52 Week Low
$8.73
$293.43
52 Week High
$22.45
$435.92

Technical Indicators

Market Signals
Indicator
ROIV
CSL
Relative Strength Index (RSI) 62.44 58.53
Support Level $20.14 $318.33
Resistance Level $21.48 $340.00
Average True Range (ATR) 0.71 7.85
MACD 0.00 2.46
Stochastic Oscillator 65.96 71.15

Price Performance

Historical Comparison
ROIV
CSL

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About CSL Carlisle Companies Incorporated

Carlisle Companies Inc is a holding company. The company manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. The company is organized into two segments including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing underlayments, integrated air and vapor barriers, spray polyurethane foam and coating systems, and others. The majority of the company's revenue comes from the Carlisle Construction Materials segment, and more than half of the total revenue is earned in the United States.

Share on Social Networks: